Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PH-797804 | 0.6 | uM | 3 | G-CSF | 15.0 | 55 | ||||
0 | G-CSF | 27.5 | 46 | ||||||||
0 | G-CSF | 29.0 | 43 | ||||||||
0 | G-CSF | 24.5 | 68 | ||||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | G-CSF | 24.0 | 51 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | G-CSF | 19.0 | 73 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | G-CSF | 21.0 | 87 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | G-CSF | 26.0 | 65 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | G-CSF | 21.0 | 81 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | G-CSF | 22.0 | 73 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | G-CSF | 22.0 | 56 | ||||
RA2159 | 4 | G-CSF | 24.0 | 61 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | G-CSF | 24.0 | 64 | ||||
N2645 | 4 | G-CSF | 22.0 | 64 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | G-CSF | 19.0 | 72 | ||||
RA2708 | 4 | G-CSF | 20.0 | 74 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 26.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 39.0 | 60 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 21.5 | 86 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 23.0 | 80 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 24.0 | 77 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 21.0 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 46.0 | 69 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 67.0 | 69 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | G-CSF | 41.0 | 50 |